SecBot SecBot
6-K ·Filed Aug 13, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SEC0001575872-26-000568
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for any subsequent announcements regarding a replacement for the CEO of API and Services, as the role is critical to the company's active pharmaceutical ingredients and services segment. The long notice period suggests an orderly transition, reducing near-term disruption risk.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$12.42
T+0 close · Aug 13, 2026 · via day close
Latest settled
−2.50%
T+5 · $12.11
Vs SPY
−0.53%
α at T+5
Next horizon
T+20
due 2mo ago
  1. T+0 · Aug 13 $12.42entry
  2. T+1 · 3mo ago −1.21%α −1.01% · $12.27
  3. T+5 · 3mo ago −2.50%α −0.53% · $12.11
  4. T+20 · due 2mo ago Pending
  5. T+60 · due 11d ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's Laboratories filed a 6-K disclosing the resignation of Mr. Deepak Sapra, CEO of API and Services and Senior Management Personnel, effective November 12, 2026, to pursue opportunities outside the company. This is a routine senior management departure with a standard notice period, and no financial impact or strategic shift is indicated.

Key Facts

  • Mr. Deepak Sapra resigned as CEO, API and Services and Senior Management Personnel.
  • Resignation effective from close of business on November 12, 2026.
  • He will remain with the company until the effective date to ensure a smooth transition.
  • He served at Dr. Reddy's for over 23 years since 2003.
  • Reason cited: to pursue opportunities outside the company.

Financial Impact

No financial impact disclosed; routine management change.

Risk Factors

  • Potential operational disruption if a suitable replacement is not identified before the effective date.
  • Loss of institutional knowledge from a 23-year veteran in a key business segment.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
31% bullish (45 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000568
Document: 0001575872-26-000568-index.html0001575872-26-000568
Document: 0001575872-26-000568.txt0001575872-26-000568

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026